Board of Scientific Counselors

The Board of Scientific Counselors previews and evaluates the intramural research programs of the National Human Genome Research Institute (NHGRI) and provides periodic technical and scientific peer review of the work of individual investigators in the Division of Intramural Research (DIR).

Board members meet, at the call of the chair, throughout the year, for the purpose of site visits to individual research branches and at least once a year for the full board meeting at which they present their evaluations.

Board of Scientific Counselors Charter

Lucile L. Adams-Campbell, Ph.D.
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Term ends 6/2021

Euan Ashley, BSc, MBChB, FRCP, DPhil, FAHA,  FACC, FESC (ad hoc)
Stanford University Cardiovascular Clinical Medicine
Term ends 6/2025

Barry S. Coller, M.D.
Rockefeller University
Term ends 6/2023

Gregory Barsh, M.D., Ph.D.
HudsonAlpha Institute for Biotechnology
Term ends 6/2024

Neal G. Copeland, Ph.D. (Board Chair)
University of Texas MD Anderson Cancer Center
Term ends 6/2021

Brendan Lee, M.D., Ph.D.
Baylor College of Medicine
Term ends 6/2021

Carole Ober, Ph.D.
The University of Chicago
Term ends 6/2023

Adam C. Siepel, Ph.D. (ad hoc)
Cold Spring Harbor Laboratory
Term ends 6/2025

Sarah Tishkoff, Ph.D.
University of Pennsylvania
Term ends 6/2023

Tim M. Townes, Ph.D.
University of Alabama at Birmingham
Schools of Medicine and Dentistry
Term ends 6/2021

Susan W. Marino, Ph.D.
Recording Secretary